Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.45%||178.89||0.7%||$1413.67m|
|BMY||Bristol-Myers Squibb Co.||1.73%||78.24||1.0%||$1172.57m|
|MRK||Merck & Co., Inc.||0.85%||93.10||0.7%||$1086.85m|
|LLY||Eli Lilly & Co.||0.70%||301.48||1.1%||$869.46m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.64%||141.50||0.0%||$430.00m|
|HZNP||Horizon Therapeutics Plc||2.29%||92.90||5.4%||$202.12m|
|NVO||Novo Nordisk A/S||3.02%||106.36||0.1%||$174.32m|
Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China.